In February, the company announced plans for a share issue of up to 1.64 million shares, which will represent 14 percent of the company’s increased capital.
– Our intention is that this share issue will be the last one before the commercialization of the Genomtec ID platform – said Miron Tokarski, CEO and major shareholder of Genomtec.
Learn more here: https://www.pb.pl/genomtec-chce-sie-wzmocnic-emisja-1179313
